Skip to main content

Published locations for FDA approves topical roflumilast for psoriasis in children aged 6-11

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves topical roflumilast for psoriasis in children aged 6-11

User login

  • Reset your password
  • /content/fda-approves-topical-roflumilast-psoriasis-children-aged-6-11
  • /edermatologynews/article/265757/psoriasis/fda-approves-topical-roflumilast-psoriasis-children-aged-6
  • /familypracticenews/article/265757/psoriasis/fda-approves-topical-roflumilast-psoriasis-children-aged
  • /pediatricnews/article/265757/psoriasis/fda-approves-topical-roflumilast-psoriasis-children-aged-6-11
  • /rheumatologynews/article/265757/psoriasis/fda-approves-topical-roflumilast-psoriasis-children-aged-6
  • /pediatrics/article/265757/psoriasis/fda-approves-topical-roflumilast-psoriasis-children-aged-6-11
  • /rheumatology/article/265757/psoriasis/fda-approves-topical-roflumilast-psoriasis-children-aged-6-11
  • /dermatology/article/265757/psoriasis/fda-approves-topical-roflumilast-psoriasis-children-aged-6-11
  • /familymedicine/article/265757/psoriasis/fda-approves-topical-roflumilast-psoriasis-children-aged-6